Hong Kong Insurance Stock News

Guangdong Investment (SEHK:270) has issued preliminary guidance for 2025, flagging an expected 43% rise in consolidated profit attributable to shareholders. The increase is mainly linked to a business reshuffle and lower financing and administrative costs. See our latest analysis for Guangdong Investment. Guangdong Investment’s guidance arrives after a mixed price pattern, with a 7.58% 1 month share price return and a 9.94% year to date share price return, alongside a 36.12% 1 year total...

Affluent Foundation Holdings (SEHK:1757), now renamed Global Chinese Business Club, has shifted its focus toward Hong Kong financial services, including securities dealing and advisory, asset management, and trust services, following its origins in the construction sector. See our latest analysis for Affluent Foundation Holdings. The share price has surged over recent months, with a 30 day share price return of 100.24% and a very large 1 year total shareholder return. This suggests investors...

Why Xtep’s latest bond deal matters after Saucony’s strong year Xtep International Holdings (SEHK:1368) completed a HK$500 million zero coupon convertible bond offering shortly after reporting over 30% year-on-year retail growth for Saucony in both the fourth quarter and full year 2025. See our latest analysis for Xtep International Holdings. The HK$500 million convertible bond comes after a mixed share price patch, with Xtep International Holdings’ latest close at HK$5.2. This reflects a 7...

Lenovo Group (SEHK:992) drew fresh attention after using ISE 2026 to unveil new ThinkSmart Core Gen 2 based meeting room solutions with Huddly, highlighting its push into AI powered collaboration hardware and services. See our latest analysis for Lenovo Group. Despite the ThinkSmart launch, recent consumer focused sales events, and sustainability recognition, Lenovo's 7 day share price return of 4.17% sits against a 90 day share price return decline of 16.82%. The 3 year total shareholder...

Why Guoco Group’s latest earnings and dividend matter now Guoco Group (SEHK:53) is back on investors’ radar after its H1 2026 earnings call on 29 January and a newly declared interim dividend of 1.00 pence per share, both pointing squarely to shareholder returns. See our latest analysis for Guoco Group. Guoco Group’s share price has picked up recently, with a 5.6% 1 month share price return and a 5.9% year to date share price return. The 1 year total shareholder return of 8.6% points to...

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...

With a price-to-earnings (or "P/E") ratio of 33.4x ECI Technology Holdings Limited ( HKG:8013 ) may be sending very...

It's not a stretch to say that COSCO SHIPPING International (Hong Kong) Co., Ltd.'s ( HKG:517 ) price-to-earnings (or...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Key Insights Qinqin Foodstuffs Group (Cayman)'s significant insider ownership suggests inherent interests in company's...

SiS Mobile Holdings Limited's ( HKG:1362 ) price-to-earnings (or "P/E") ratio of 74.1x might make it look like a strong...

To the annoyance of some shareholders, Sundy Service Group Co. Ltd ( HKG:9608 ) shares are down a considerable 32% in...

Despite an already strong run, S.A.I. Leisure Group Company Limited ( HKG:1832 ) shares have been powering on, with a...

JBB Builders International Limited ( HKG:1903 ) shareholders have had their patience rewarded with a 51% share price...

To the annoyance of some shareholders, China Tianrui Automotive Interiors Co., LTD ( HKG:6162 ) shares are down a...

With a median price-to-earnings (or "P/E") ratio of close to 12x in Hong Kong, you could be forgiven for feeling...

Pokfulam Development Company Limited's ( HKG:225 ) investors are due to receive a payment of HK$0.32 per share on 6th...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Tax jitters and AI promotions put Tencent in focus Interest in Tencent Holdings (SEHK:700) has picked up after a sharp selloff in Chinese tech stocks tied to possible higher value added taxes on internet firms, alongside Tencent's cash giveaways promoting its Yuanbao AI app. See our latest analysis for Tencent Holdings. The recent selloff in Chinese tech, combined with Tencent's Yuanbao promotions and fresh competition around AI giveaways, has contributed to a 30 day share price return of an...

WuXi Biologics (Cayman) (SEHK:2269) announced new alliances with Vertex Pharmaceuticals and Sinorda Biomedicine for co-development and manufacturing of biologics targeting autoimmune diseases. The company also expanded its agreement with HanchorBio to cover next generation fusion protein programs. Together, these collaborations broaden WuXi Biologics' role as a global contract research, development and manufacturing partner across multiple therapeutic modalities. WuXi Biologics focuses on...

BYD (SEHK:1211) is back in focus after reporting a 30% year on year drop in January sales to about 210,000 vehicles, its fifth straight monthly decline, which coincided with weaker government incentives. See our latest analysis for BYD. The weak January sales and reduced incentives have come after a tough spell for the shares, with a 7 day share price return of 10.36% and a 1 month share price return of 8.01%, leaving the share price at HK$91.25. Even so, the 1 year total shareholder return...

In recent days, Ford Motor confirmed it is in talks with Zhejiang Geely Holding Group about using Ford’s excess plant capacity in Valencia, Spain, potentially including platform and technology sharing for European vehicle production. This prospective collaboration could allow Geely to assemble cars within the European Union, helping reduce tariff exposure while giving Ford a way to improve utilisation of its underused facilities. Next, we examine how this potential Ford manufacturing tie-up,...

Nexteer Automotive Group Limited's ( HKG:1316 ) price-to-earnings (or "P/E") ratio of 19.3x might make it look like a...

China Medical System Holdings (SEHK:867) has secured approval from China's National Medical Products Administration to start clinical trials for CMS-D017, an oral complement factor B inhibitor targeting paroxysmal nocturnal hemoglobinuria. See our latest analysis for China Medical System Holdings. Trading at HK$14.58, China Medical System Holdings has seen firm momentum recently, with a 7 day share price return of 4.59%, a 30 day share price return of 7.44%, and a 1 year total shareholder...